Mayne Pharma Group Ltd.

Last Updated:
4:10 pm
Friday, June 20, 2025
Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment is involved in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty Products segment includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment manufactures and sells branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.
Market Cap
AU$410.29M
Volume
555673
Open
5.20
AU$
High
5.21
AU$
Low
5.03
AU$
Shares On Issue
81M
52 Week Low
3.74
AU$
52 Week High
7.31
AU$
Website
www.maynepharma.com
Sector
Healthcare
Pharmaceuticals: Major
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report

Related

Our friendly team is here to help.

If you have any questions or feedback about our service, please feel free to contact us.